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for membersBuzzwords: ‘interdisciplinary’, ‘innovative’,
‘integrative’. These get attention. In grants they help
get the dosh; in manuscripts they improve the
chances of publication. Is this because of a deeply
entrained Pavlovian expectation, with the reviewer’s
score destined to be higher than if these words
were absent? Or is this a reflection of the inherent,
and possibly even self-evident, virtue of broad-
ranging approaches to science, ones that also
capture the imagination? Education, dissemination of
knowledge, and grants are key themes of this issue.
Endocrinologists excel at integrative approaches in science and clinical
practice, but there can be few examples as cross-cutting as the recent
performance of The Tide Tables (see page 16). A Wellcome Trust-supported
venture, this was a highly novel approach using a stage production to interrogate
the biology of mid-life, whilst educating (without lecturing) about endocrinology.
Saffron Whitehead (past Editor of this newsletter) was deeply involved in the
project, providing the endocrinological input to the artistic flair. If you have the
chance, the website link gives video insight into what it was all about, which,
perhaps, may inspire fresh approaches to education about our subject.
No less successful in public engagement, however, was the more traditional
lecture-based approach delivered by Steve Franks in Oxford on ‘How hormones
shape your life’. It is yet another example of the external collaboration activities
of the Society, this time with Science Oxford, and you can read more about it on
page 15. The ‘young ones’ are also ‘doing it for themselves’, with the Voice of
Young Science (part of the charity Sense About Science) running workshops for
early career scientists in media training and communication of science. These
explain how best to mitigate against the misrepresentation and hype that are all
too common - Emma Ross reports on page 8.
On page 6, we find the Endo Train has steamed on to Bristol. Stafford
Lightman gives a superb tour de force of the history and vast depth and breadth
of endocrinology and diabetes in that city. This is the third stop in this series,
and several other centres have made contact to arrange for the train to call on
them - it could also be your chance, just let us know.
The Society is extremely generous in its grant and award-giving activity. The
Young Endocrinologists Prize Lecturers, Georgia Papacleovoulou and Tom Barber,
tell us the background to their excellent lectures presented at the BES in 2009
on page 13. On pages 10-12, the numerous recipients of other grants give short
reports on their work, hopefully whetting the appetites of members to apply in
the future.
This year also saw another highly successful undergraduate essay prize
competition, with 55 entries. In his winning essay, Adam Hexter considers the
true cost of the ‘credit crunch’, an excerpt of which appears on page 14.
Meanwhile, fostering careers sees further development in 2009, and Joy Hinson
reports on the activities of a new committee on page 15.
Finally, Hotspur (page 18) has clearly been in a reflective mood, and from his
creative garret comes a philosophical muse on matters of audience participation
and behaviour. Perhaps it is time for a change in the modus operandi when we
come to course evaluation?
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access for members
From 2010, all members of the Society for Endocrinology will have
access to the most up-to-date research published online in Journal of
Endocrinology, Journal of Molecular Endocrinology and Endocrine-Related
Cancer automatically with their membership.
Access to the journals will be gained via the BioSciAlliance website, a
new portal designed to enable you to manage your membership effectively
(www.bioscialliance.org). This superb new benefit of membership will allow
you to search the literature and follow logical pathways in research through
reference-linking to and from other journals in the field.
Print subscriptions will continue to be available as an option for members,
at the lowest available prices.
New Council members needed
Professor Kevin Docherty, Dr Rob Fowkes and Professor Mike Wallace
will retire from Council in March 2010, having served their 4-year terms
of office. A further position will be left vacant when Professor Graham
Williams becomes Treasurer on 1 January 2010.
Full members are requested to make nominations to fill these four
vacancies. A nomination form is included with this mailing or can be
downloaded from www.endocrinology.org/about/committee/council.html.
To provide the correct balance on Council, the Society is seeking three basic
science members and one clinical member to fill the vacancies. The deadline
for nominations is 11 December 2009.
Re-election of Officers
The Society’s Officers must offer themselves for re-election in their second
and subsequent years of office. The current post-holders are Julia Buckingham
(Chairman), Paul Stewart (General Secretary) and Márta Korbonits
(Programme Secretary), who are entering their second year of office.
If any member wishes to propose an alternative name for any of the
above posts, please contact Julie Cragg (julie.cragg@endocrinology.org)
by 2 November.
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Society for Endocrinology Clinical Update
Renaissance Manchester Hotel, Manchester, UK 
4 December 2009
Society for Endocrinology 
Regional Clinical Cases Meeting
Edinburgh, UK 
23 February 2010
Society for Endocrinology 
National Clinical Cases Meeting
London, UK 
15–18 March 2010 
Society for Endocrinology BES 2010
Manchester Central Convention Centre, Manchester, UK
Abstract deadline: 16 November 2009
Benevolent Fund
The Trustees of the Benevolent Fund of the Physiological Society would
like to draw members’ attention to the Fund. It exists to help anyone
who ‘by the nature of their employment can be considered to have
contributed to the advance of physiology’ and who is in ‘necessitous
circumstances’. For more details see www.physoc.org/site/cms/
contentCategoryView.asp?category=404.
Prize draw winners
In June, we held a prize draw of
members who had completed a
direct debit mandate for payment of
membership subscriptions. The prize
was a £50 Amazon voucher, which
was won by Dr R Almohammed from
Scunthorpe General Hospital.
A second prize draw of all the
respondents to our membership
questionnaire was won by
Dr C Capatina from Bucharest, who
also received a £50 Amazon voucher.
Congratulations
The Society is delighted to announce
that Professor A Dell (Division of
Molecular Biosciences, Imperial College
London) was awarded a CBE for services
to science in the Queen’s Birthday
Honours List. We also congratulate
Professor Mike Wallace, who has been
made a visiting Professor at the
University for Strathclyde, Institute of
Pharmacy and Biomedical Science,
Professor Joy Hinson, who has been
made Professor of Endocrine Science at
Queen Mary University of London and
Dr Waljit Dhillo, who has been made a
Reader in Endocrinology & Metabolism
at Imperial College London.
WITH REGRET
We are sorry to announce the deaths
of Senior Members Professor P Krohn
and Professor R Coupland, and Full
Member Dr K MacLeod (whose
obituary appears on page 4).
New members
We are pleased to welcome the new
members approved by Council in
May. There are 35 from the UK, and
3 from the rest of the world. Send your suggestions for
Society BES 2011
The Society welcomes scientific suggestions for the 2011 Society for
Endocrinology BES meeting, for consideration by the Programme Committee.
If there are any sessions you would like to see included, please submit them by
the end of January 2010 through www.endocrinology.org/meetings/
ScientificSessions/index.aspx.OBITUARY
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Updated careers website
The Society’s careers web pages have had a
makeover. Visit www.endocrinology.org/careers for
the latest jobs, grants and prizes in endocrinology, to
browse through the career profiles, or to search for a
Masters or short course in endocrinology. If you have
a vacancy available in your department, please send
us the details to careers@endocrinology.org. We’ll
publicise it free of charge on the site.
And while you’re browsing the careers pages, make
sure you don’t miss the new section ‘A biomedical basis
for life - alternatives to academia’. We’ll be posting a
selection of career profiles from endocrinologists who
have chosen alternative science careers. Do you know
anyone who has left academia to pursue an alternative
career? If so, we’d like to hear from them. Please forward
their contact details to careers@endocrinology.org.
To be an outstanding endocrinologist you need to
be a true all-rounder. Kenneth MacLeod was a rare
doctor who excelled as a specialist endocrinologist,
general physician, teacher, researcher, and academic
leader. He will be greatly missed after his tragic death
aged 46 on 11 July 2009.
Ken qualified in 1986 from Aberdeen Medical School
and then trained in general medicine, hypoglycaemia
research, diabetes and endocrinology in Aberdeen and
Edinburgh. His talents were rapidly appreciated when he
moved south to Exeter, and in 1996 he was appointed as
a consultant endocrinologist.
He was a leading researcher and national authority on
hypoglycaemia in diabetes, and served on the Secretary of
State’s Advisory Panel on Driving and Diabetes. His research
always asked important questions and he was not afraid to
publish findings that went against the prevailing dogma.
Ken was a wonderful, enthusiastic educator for patients,
students and junior and senior colleagues. He played a
leading role in establishing the Peninsula Medical School and
was the Associate Dean for Exeter. As Director of Clinical
Studies he ensured the new curriculum never lost sight of the
key knowledge and skills a young doctor needed.
Ken MacLeod was the dedicated doctor we all would
like to be. He had one priority - his patients - and was
never happier than during a busy clinic. Even in the face
of increasing medical school and national responsibilities
he refused to cut down his clinical commitments in
endocrinology, diabetes and general medicine. Clinics
were reorganised into any available time slot to make
sure he could see his patients!
Ken was an inspirational leader and had great vision.
He masterminded the setting up of the new Diabetes,
Endocrinology and Vascular Health Centre at the Royal
Devon and Exeter Hospital. It was his determination that
ensured that the new Peninsula Medical School building
had a crucial extra floor added to accommodate
researchers.
His great personal warmth pervaded everything he
did. He was not just the brains of the Exeter Diabetes
and Endocrinology Department but also the heart. We
will greatly miss his wonderful ability to help people feel
confident and genuinely valued.
He was a committed family man and is survived by
his wife and three children.
ANDREW HATTERSLEY
Society of Biology
The Privy Council formally approved the revised
Royal Charter in July, allowing integration of the
Biosciences Federation and Institute of Biology to
form the Society of Biology from 1 October 2009.
All members of the organisations have become
members of the new Society.
Prof Dame Nancy Rothwell is the first President,
Dr William Marshall the Honorary Treasurer and
Prof David Coates the Honorary Secretary. The Chief
Executive Officer had been appointed but not
announced when The Endocrinologist went to press.
The Interim Council forms the basis of the new
Council, with a managed transition of existing
members to the new profile of elected and appointed
members from the two colleges (organisational and
individual). Council members are to be elected by the
new Society’s membership.
It is important that members contribute their
views, ideas and questions about the Society of
Biology. Find out more at www.newbio.info. Send
any comments by email or by adding to the blog:
http://newbioinformation.blogspot.com.
KENNETH M MACLEOD
Tell us your news!
Have you been contacted by the press? Are you going to
be interviewed by a radio station or appear on the
television? The Society’s Public and Media Relations team
is keen to hear from members who are working with the
media. Please let us know of any upcoming interviews at
media@endocrinology.org, so we can publicise them to
the membership.Have you had difficulty in getting hold of funding
to make your paper open access? Although many
funders, and indeed now even some institutions,
insist that you make your published paper free to all
within a short deadline, it’s not always clear how you
are to pay the ‘author-side’ fees needed to make 
free-to-view publication viable. Universities UK has
published a report to tackle this important question.
Some mandating bodies have not made the
connection that their mandates have funding implications,
perhaps imagining that making copies of articles freely
available on open repositories has no repercussions for the
journals upon which they depend. There are others which
have clearly budgeted to provide these funds but, even
then, it is not always clear to authors how they can get
hold of them via their institutions. Only a very small
number of UK higher education institutions currently have
any clear arrangements in place.
UUK’s report, published jointly with the Research
Information Network, seeks to address these concerns
by setting out guidelines for the key stakeholders. The
Society’s staff (Sue Thorn and Steve Byford) were active
participants in drawing up the report. The Biosciences
Federation has also endorsed it. 
The report recommends the following:
• HEIs should each set up a dedicated budget to pay
author-side open access publication charges.
• Funding bodies should clarify how they will provide
support for researchers to meet their open access
policies, especially regarding the payment of open
access fees.
It also suggests that authors should make use of
resources such as the Biosciences Federation’s Authors’
Guide to UK funders’ policies on Open Access, and
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New Chair for BBSRC
The formal appointment of Professor Sir Tom Blundell
FRS FMedSci as the new Chair of the Biotechnology and
Biological Sciences Research Council (BBSRC) was
announced on 18 June 2009 by the Department for
Business, Innovation and Skills.
Results: SCE in Endocrinology
and Diabetes 
A total of 39 candidates sat the first diet of the Specialty
Certificate Examination in Endocrinology and Diabetes in
May 2009. The overall pass rate was 38.5% with 64.3% of
the UK trainees passing the examination. For further
information visit www.mrcpuk.org/SCE/Pages/Results.aspx.
familiarise themselves with their funder’s policies and the
arrangements within their institution. Publishers are
asked to give clear advice to authors on their open access
requirements and on the associated fees.
If the report’s recommendations are followed, it will
represent an important step towards a joined-up approach
to open access, and help remove the corrosive effects of
unfunded mandates.
STEVE BYFORD
FURTHER READING
Paying for open access publication charges (Report of Universities UK
and the Research Information Network) www.rin.ac.uk/openaccess-
payment-fees
Authors' Guide to UK funders' policies on Open Access (Biosciences
Federation) www.bsf.ac.uk/journals/journals_authors'guide.htm
Society for Endocrinology policy on self archiving on institutional and
other repositories www.endocrinology-journals.org/misc/
archiving_policy.dtlBristol was always one of
the great port cities of the
UK - and the second greatest trading city after
London in the 18th century. It was ideally
located to develop trading links with
Europe, Africa and the American
‘Colonies’, and became rich from
activities related to the slave trade,
wine, spirits and tobacco. Not,
perhaps, an auspicious ethical
starting point for 21st century
biological science, but important
history that must not be forgotten.
But Bristol’s place in history is also
reflected by Isambard Kingdom Brunel’s legacy - the SS
Great Britain, the Clifton Suspension Bridge, and one of the
world’s first railway stations. We have the replica of John
Cabot’s ship, The Matthew, to remind us of his voyage to
North America from Bristol in the 15th century. And then
there are Concorde, the BBC Natural History Unit, Bristol
International Balloon Fiesta, Wallace and Gromit, and Banksy,
a local street artist whose activities are renowned worldwide.
Endocrinology - and in particular neuroendocrinology -
also has a long history in Bristol. Hans Heller was
appointed lecturer in charge of the newly created
Department of Pharmacology in 1942, became Professor
of Pharmacology in 1949 and developed an internationally
renowned centre for research on the regulation of the
neurohypophysis. His symposia on ‘The neurohypophysis’
in 1956, ‘Neurosection’ in 1961 and ‘Subcellular
organisation and function in endocrine tissues’ in 1970
attracted endocrinologists from all over the world.
Barry Cross, a protégé of Geoffrey Harris, was
Professor of Anatomy from 1967 to 1974, and developed
the technique of electrophysiology in the hypothalamus.
He trained, amongst others, Richard Dyball, John Morris,
Dennis Lincoln and Richard Dyer. Meanwhile, Brian
Pickering’s MRC unit moved to the Department of
Anatomy following Hans Heller’s retirement and
continued the excellent work on understanding the
regulation of neurohypophyseal secretion.
The opportunity for me, as a neuroendocrinologist, to
come to such an excellent university with such a marvellous
history in endocrinology was one I could not resist. I came
from Charing Cross and Westminster Medical School with
my clinical scientist colleague, Andrew Levy, who was soon
joined by David Wynick and Colin Dayan, as well as our
basic scientific colleagues Chas Chowdrey, Michael Harbuz
and David Jessop. We moved to an area of refurbished
laboratories in what had been dermatology wards around
the back of the Bristol Royal Infirmary (BRI). These were
exciting times and we were soon joined by superb basic
scientists including David Murphy, Craig McArdle, James
Uney, Nola Shanks, Christopher Lowry, Stephen Lolait, Anne-
Marie O’Carroll, Hans Reul, Astrid Linthorst and Kei Cho.
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After moving around the bowels of the BRI several
times, we obtained a Wellcome Trust SRIF Award, which,
with a grant from the HEFCE and support from the
University, allowed us to build the Dorothy Hodgkin
Building, which now houses the Henry Wellcome
Laboratories for Integrative Neuroscience and
Endocrinology. This has transformed our ability to perform
integrative research from the most basic cell biology
through to physiological studies and clinical translation.
Clinical endocrinology has expanded over the whole
of the Bristol campus. In the BRI, my own research group
works on the HPA axis, especially its regulation in health
and disease. We have been particularly interested in the
regulation of the ultradian pattern of cortisol secretion
and how this regulates gene transcription. These in vivo
and in vitro studies are now being applied to translational
work in man, with potentially very important implications
for steroid therapeutics, including a new understanding of
the inadequacy of current steroid replacement regimens.
Andrew Levy is an internationally renowned authority
on the pituitary gland and the aetiology of the development
and maintenance of pituitary tumours. He has shifted the
previously held paradigms on their causes and his concept
of ‘exuberant normality’ remains the best conceptual
understanding of cell activity in these fascinating tumours.
David Wynick has focused on the role of the
neuropeptide galanin in neuropathic pain and neuronal
protection. He is translating his work into preclinical drug
development funded by a Wellcome Trust Seeding Drug
Discovery Award, and most recently has started a research
out-patient clinic in Bristol, focused on improving the
management of diabetic neuropathic pain.
Colin Dayan’s interests cover both the thyroid axis and
the immunotherapy of type 1 diabetes. He runs the joint
thyroid eye clinic at Bristol Eye Hospital and is the principal
investigator in the multicentre combined immuno-
suppression and radiotherapy in thyroid eye disease study,
in close collaboration with Moorfields Eye Hospital and
four other centres in London. His unit has also conducted
the largest trial of combined T4/T3 therapy in the world,
and has made fascinating progress in identifying common
genetic variations that effect thyroid hormone action.
Together with Susan Wong and Mark Peakman
(King’s College London), he has collected 650 adult cases
with newly diagnosed type 1 diabetes for immunological
studies and has conducted the first phase 1 trial of
peptide immunotherapy. Also, with Rob Andrews, he has
established the early ACTID randomised controlled trial
of intensive diet or intensive diet and exercise versus
usual care in newly diagnosed type 2 diabetes. He runs
our insulin pump clinic and, with Richard Smith, the
regional pancreas transplant programme.
Susan Wong joined us from Yale University and has a
major research focus on the immunopathogenesis of type 1
diabetes. She is interested in the role of CD8 T-cells, B-cells
all aboard for... Bristol
Stafford Lightman greets us as we disembark for a tour of
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and innate/adaptive immune interface in the pathogenesis
of type 1 diabetes. Her work in animal models is carried out in
parallel with translational development of immunotherapy
for type 1 in collaboration with Colin Dayan.
Rob Andrews, a senior lecturer in our department, has
developed one of the country’s largest medical obesity
clinics at Musgrove Park Hospital in Taunton. Last year saw
over 1400 referrals and more than 400 surgical procedures.
They have now been made lead centre in the south-west as
an international centre of excellence for bariatric surgery.
This programme importantly has a large research portfolio
looking at the effect of weight loss and surgery on gut
hormones and insulin secretion, signalling and sensitivity.
We have been fortunate in the appointment of Karin
Bradley as full-time NHS consultant endocrinologist. With
a DPhil in molecular endocrinology from the University of
Oxford and extensive clinical experience, she has helped
to optimise care for patients with multiple endocrine
neoplasia and other rare genetic endocrine syndromes.
She has developed a regular monthly neuroendocrine
tumour multidisciplinary team at the BRI, which attracts
referrals from across the south-west of England.
Karin is also the endocrinology representative on the
steering group investigating service delivery for ‘late
effects’ patients living in the Peninsula region, and is
helping to establish a co-ordinated local clinical service
for these survivors of childhood cancer. Her interests and
roles include endocrinology in a critical care setting and
endocrine disorders during pregnancy, as well as diabetes
care and general medicine. She has recently been joined
by a second NHS colleague, Bushra Ahmad.
The University Hospitals Bristol NHS Foundation Trust
(UHBT) also has an extremely active paediatric endocrine
programme. It has one of the UK’s largest obesity
services, run by Julian Hamilton-Shield, and one of the
UK’s largest paediatric diabetes services, with an
emphasis on research into rare forms of diabetes,
neonatal diabetes, Down’s syndrome and autoimmunity.
Julian in particular has been the driving force behind
the discovery of 6q imprinting anomalies in neonatal
diabetes, KCNJ11 mutations causing neonatal diabetes and
the discovery of genes involved in neonatal glucose
metabolism, PTFA1, ABCC8, HNF4 alpha and GLUD1
mutations and the cause of neonatal hyperinsulinaemia.
Collaborative studies with Jeff Holly have focused on insulin
resistance in obesity, including studies on adipocytes with
respect to adipogenesis and insulin resistance. Liz Crowne is
Chair of the British Society for Paediatric Endocrinology and
Diabetes, and her research has concentrated on the late
effects of cancer treatment on endocrine systems.
Reproductive endocrinology is led by David Cahill and
Andrés López Bernal. David’s focus is on the endocrine
status of serum and follicular fluid and its relationship
with successful in vitro fertilisation. His data suggest
differential regulation in patients with minor degrees of
endometriosis. Andrés concentrates on CRH and oxytocin
signalling in the normal and pregnant myometrium and
the abnormalities that occur in premature labour.
In north Bristol, Edwin Gale and Polly Bingley lead a
major diabetes research centre. They have developed the
current model for predicting future onset of diabetes in
close relatives of an affected child. This led on to ENDIT
(1994-2003), a multinational intervention trial. Their
interest in the epidemiology of type 1 diabetes has led to
a close collaboration with Kathleen Gillespie, studying
the role of NK cells in autoimmune diabetes and
immunogenetic characterisation of diabetes in Down’s
syndrome. Edwin played a prominent role in the early
stages of the EURODIAB ACE network which has greatly
clarified trends in the epidemiology of childhood-onset
diabetes in Europe. He is Editor of Diabetologia.
Jon Tobias works on metabolic
bone disease, with a particular
interest in the pathogenesis and
management of osteoporosis.
Through the unique ‘Children of the
nineties’ birth cohort, we are gaining
important insights into the factors
which affect skeletal development in
childhood, such as maternal vitamin
D exposure, fat mass, and a variety
of genetic influences. Jon helps lead
a nationwide study characterising the
phenotype and genotype of
individuals with extremely high bone
mass, which has provided further
evidence of an important link
between obesity and bone metabolism. Through the
COSHIBA study, he is examining whether a new clinical
tool can identify patients with undiagnosed vertebral
fractures. He has a strong local interest in steroid-induced
osteoporosis, exemplified by randomised controlled trials
examining the role of bisphosphonates in preventing
bone changes following steroid therapy for inflammatory
bowel disease and multiple sclerosis.
Jeff Holly was one of the first scientists to realise the
importance of IGFs and he has been an active leader in
the International Society for IGF Research. He played a
major role in working out the inter-relationship of GH,
IGF-1 and their metabolic effects, and now works closely
with epidemiologists at the Department of Social
Medicine in Bristol, studying a variety of large population
cohorts to examine how metabolic and hormonal status
relate to the development and progression of chronic
diseases, particularly the hormone-dependent cancers.
Overall, there is a wealth of clinical and basic scientific
expertise and activity in Bristol. With the proposed merger
of the UBHT and the North Bristol NHS Trust, we expect
even greater integration of research activities. We anticipate
considerable development of the translational studies in the
neuroendocrine and metabolic areas, and the synergies of
the numerous research groups and our colleagues in
Cardiff and the Peninsula will ensure Bristol remains a major
hub of novel research and endocrine clinical development.
Please visit our websites
(www.bristol.ac.uk/clinicalsciencesouth/hwline,
www.bris.ac.uk/clinicalsciencesouth,
www.bris.ac.uk/clinicalsciencenorth,
www.uhbristol.nhs.uk, www.nbt.nhs.uk), 
and if anyone is interested in discussing 
research activities with us, then you 
are of course very welcome.
STAFFORD LIGHTMAN
Dorothy
Hodgkin
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There is huge public appetite for finding out about
the latest scientific discoveries and how they might
affect how we live our lives. But all too often this
science becomes sensationalised or misrepresented in
the media, which can, at very least, misinform or give
false hope and, at worst, damage attitudes towards
the medical profession and cultivate the use of
unproven, sometimes dangerous, alternatives.
Sense About Science is a charity which works with
scientists to promote good science and evidence for
the public, and their Voice of Young Science (VoYS)
programme aims to help early career researchers
stand up for science in the public domain (see
www.senseaboutscience.org/VoYS).
VoYS held another of their successful media
workshops last June in London. These workshops aim to
give early career researchers an insight into and
understanding of how science is portrayed and
communicated in the media, and what they can do to
get involved and prevent misrepresentation.
The workshop opened with a session
on the role of science and scientists in
the public domain, and what happens
when facts are distorted or discussions
become polarised. The media-savvy
panel gave the audience an excellent
insight into how to work successfully
with the media.
Dr Robin Lovell-Badge, Head of the Division of
Developmental Genetics at the MRC, relayed his
experiences of the media coverage of his work into sex
determination in mice (cue lots of humorous tabloid
headlines) and stem cell research. His scientific expertise
in such topical issues has led to him be frequently called
into news studios as their ‘expert scientist’. He
emphasised that in these situations you have very little
time to get your key message across, and can easily get
led off track by the journalist. His advice was to identify
two or three key points that you want to get across, and
make that your sole aim of the interview. If the questions
don’t fit those key messages, ‘bridge’ to make them fit.
Catherine Collins, Chief Dietician at St George’s
Hospital, talked about the challenges of dealing with
pseudoscience communicated by unqualified individuals.
Although ‘dietician’ is a protected title, anyone can be a
‘nutritionist’, and Catherine highlighted how celebrities
and laymen alike have jumped on this bandwagon and
now give what is portrayed as ‘scientific’ advice, which is
rarely evidence-based. She emphasised the importance of
challenging the scientific credentials of such people, or
such claims, and recommended using blogs and internet
forums to get your side of the story across.
Professor Mark Enright, Professor of Molecular
Epidemiology at Imperial College London, has also had
his fair share of media exposure, particularly in relation to
the MRSA stories. His message was that if you work with
the media you can use them to your advantage, but to
be aware of their tendency to extrapolate unrealistically:
the functional consequences for humans of results from a
lab bench are often predicted too quickly.
The next session comprised a well-balanced panel of
journalists from The Sun, BBC and Nature. All raised the
issue of the strict deadlines that are imposed, which
reduce the time available for fact-checking and
contacting the key scientists involved in the research.
Whilst the panel all had strong science backgrounds, this
is not always the case, and it was evident that journalists
are at the ‘mercy’ of their subeditors, who often don’t
have much experience of science.
The panel also emphasised their need to make a story
entertaining and engaging for the public, which often
involves simplifying facts, or allowing the story to be
‘sexed up’ a little! Their advice was to ensure you have a
really good press release, as this is will be the source of
most information for their article. This means keeping it
simple and understandable, and being explicit about
why this science is novel or unique.
The day was rounded off by a Sense About Science
panel talking about the opportunities for early career
researchers to get their voices heard in debates about
science, and how to respond to bad science when you
see it. In addition, Lucy Goodchild, from the Imperial
College Press Office, spoke enthusiastically about getting
to know your press officer, and letting them help you
disseminate your research findings to a wider audience.
The main message from this panel was that there are not
enough young, enthusiastic, early career scientists
getting involved with the media, yet these are exactly
the sorts of people the media would love to have
representing science. So, go for it!
I found the workshop very helpful as it gave me an
all-round perspective of science and the media, from the
scientists who have extensive experience of their work
being disseminated into the public arena, to the
journalist whose job it is to convey it responsibly, via the
press officers who can make the difference between a
good and bad media experience.
I would recommend the VoYS media workshops to any
early career researchers who either find their own work
attracting media interest or simply have an interest in
responsible dissemination of science in the media today.
EMMA ROSS
To find out more about VoYS workshops and projects,
contact Julia Wilson at voys@senseaboutscience.org or see
www.senseaboutscience.org. The next ‘Standing up for Science’
media workshop takes place in Edinburgh on 6 November.
Standing up
for science
Emma Ross
found a 
Voice for Young
Science at a
recent media
workshop - and
suggests you
do the same.Early Career Grants 
(formerly Small Grant Programme)
We congratulate the following successful recipients of
awards made under the Early Career Grant programme
after the May 2009 deadline:
• Lesia Kurlak (Professional Unit of Obstetrics and
Gynaecology, University of Nottingham), awarded
£9621 for ‘Placental selenoproteins’ iodothyronine
deiodinases expression and activity in normal and
preeclamptic pregnancies’
• Laura Matthews (Department of Medicine, University
of Manchester), awarded £9680 for ‘Investigating Gc
sensitivity in meiosis’
• Nicole Reisch (School of Clinical and Experimental
Medicine, University of Birmingham) awarded £10 000
for ‘Analysing protein degradation of 21-hydroxylase
as a novel approach towards an improved
understanding of the molecular pathogenesis
of congenital adrenal hyperplasia’
• Kirsty Smith (Department of Investigative Medicine,
Imperial College London) awarded £6621 for
‘Augurin, a novel regulator of the hypothalamo-
pituitary-adrenal axis’
• Emily Thompson (Department of Investigative
Medicine, Imperial College London) awarded £9814
for ‘Do inherent differences in leptin sensitivity
predict age of pubertal onset and propensity to
become obese?’
Summer Studentship Winners 2009
The following departmental applications were accepted
and awarded grants in May 2009:
• Institute of Biomedical Research, 
University of Birmingham
• Queen’s Medical Research Institute, 
University of Edinburgh
• Laboratory of Molecular Signalling, 
Babraham Institute, Cambridge
• School of Clinical and Experimental Medicine,
University of Birmingham
• University of Algarve, Faro, Portugal
Undergraduate Achievement
Award 2009
These awards are to encourage excellence in the study of
endocrinology by undergraduate students by providing a
3 year grant for departments to use as they see fit to
recognise outstanding undergraduates.
The following each received an award for £300 per
annum for 3 years, following the 17 July 2009 deadline:
• Department of Physiology, Anatomy and Genetics,
University of Oxford
• School of Life Sciences, Kingston University, London
Overseas conference grants
December 2008 deadline: 129 awarded, 9 declined
April 2009 deadline: 57 awarded, 8 declined
Postgraduate Essay Prize
Competition
The Society’s new essay competition was launched earlier this year. 
Made available to members and non-members alike, it is open to all
students registered for a higher degree in the UK or Ireland at the time
of essay submission (e.g. a Masters course or research degree such as
MPhil/PhD/MDRes or equivalent). Full details can be found at
www.endocrinology.org/grants/prize_postgraduateessay.html. The winner
of this year’s competition will be announced in a subsequent issue.
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Grants and awards 2009
Welcome to this special section on the Society’s grant and award activities. As many of you know, the Society
has been able to increase the budget for these activities considerably. They include Early Career Grants
(previously termed Small Grants), Summer Studentships and support for conferences, laboratory and clinical
department visits.
Following the success of our grant and award schemes, we have launched this annual update of the awards made
during the year, reports from some of the recipients, and just some of the positive feedback we have received from
Society events.
Thank you for all the comments you have supplied via forms and email in the past year. It really helps us mould our
meetings better and match awards to members’ needs.
For information about all the Society’s grants see the website at www.endocrinology.org/grants. The next deadline
for the Early Careers Grant will be 27 November 2009.
ALAN MCNEILLY, GRANTS PANEL CHAIR, SCIENCE COMMITTEE CHAIR
Reports on the Patient Support Grants will be published in the next issue.
AWARD WINNERS
CORPORATE SPONSORS
We take this opportunity to thank all
our corporate sponsors for their
generous support, which enables the
Society to offer many of their grants to
fund endocrinologists at all stages of
their careers. For more information
about the Society’s corporate sponsors,
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Lab Visit Grant Report 2009:
11βHSD1 and glucocorticoid
production in adipose tissue
My clinical and laboratory studies focus on the
enzyme 11β-hydroxysteroid dehydrogenase type 1
(11βHSD1) and its contribution to glucocorticoid
production in adipose tissue. This grant enabled me
to spend a period of time at the Oxford Centre for
Diabetes, Endocrinology and Metabolism (OCDEM),
where I worked under the supervision of Dr Fredrik
Karpe. The purpose of my study was to measure
11βHSD1 directionality across human subcutaneous
adipose tissue in vivo.
Over the past 2 years of my PhD in Edinburgh, I have
developed and validated a new method to measure
glucocorticoid inactivation in vivo using a stable isotope
tracer (d2-cortisone). The aim was to use this new stable
isotope tracer along with an established cortisol tracer 
(d4-cortisol) to measure and compare glucocorticoid
(cortisol and cortisone) generation across two metabolically
important tissues, subcutaneous abdominal adipose tissue
and muscle. In addition, we aimed to assess the effects of
hyperinsulinaemia on enzyme activity and directionality.
Arterio-venous (AV) sampling across adipose tissue
allows the measurement of abdominal adipose
glucocorticoid production. This technique was developed
by Keith Frayn and colleagues in Oxford. So, the purpose
of my visit was to learn this technique and apply the new
tracer method I had developed, to better understand
glucocorticoid generation in these tissues.
This project also provided me with the opportunity
to learn other clinical research techniques, e.g. adipose
biopsies, that I will be using in future studies in Edinburgh.
Although the plasma samples and blood flow data
from this study are not yet processed, I hope that the
results from this project will lead to published papers and
presentations at local and national scientific meetings.
Furthermore, information from this study on the
regulation and activity of adipose 11βHSD1 will provide
clinically relevant information for the 11βHSD1 inhibitor
drug-development programmes.
I am grateful to the Society for Endocrinology for the
Lab Visit Grant towards this project, allowing this first
substantive collaboration at both sites. I am also grateful
to the staff and volunteers in Oxford for their invaluable
help with this study.
KATHERINE HUGHES
Sponsored Seminar Grant 2008:
Integrated mechanisms of cellular
identity and homeostasis
The Babraham Institute in Cambridge celebrated
60 years of science with an International Diamond
Jubilee conference on 26 and 27 June 2008. The
programme comprised top international speakers,
including several former Babraham Institute scientists
(Azim Surani, Robert Feil, Nullin Divecha, Brigitta
Stockinger and Steve Jameson).
Research interests at Babraham have clearly evolved
considerably over the past 60 years. The study of
endocrinology has been a key feature of the Institute’s
remit, and the themes of the conference reflected the
main areas that have led from this - signalling,
development and immunology. The event brought
together international leading researchers in epigenetics
and signalling to explore two convergent themes
embracing these topics: epigenetic mechanisms in
development, and cellular responses to the environment.
These themes evolved from the Babraham Institute’s
vision of the future need for integrative approaches both
inside and outside the nucleus.
The Institute has a long-standing reputation as a
signalling centre of excellence. Recently several signalling
groups have begun a collaborative drive to combine their
respective strengths using a systems biology approach.
So the ‘cellular responses to the environment’ component
focused on large-scale integrative strategies for
understanding cellular signalling, bringing together several
leading scientists who are applying systems biology
approaches to complex signalling questions. These
included Kevin Shokat (chemical genetics of protein
kinases), Anjano Rao (genome-wide human and Drosophila
RNAi screens identifying novel signalling regulators), Dennis
Bray (systems biology pioneer, mathematical modelling of
signalling pathways in bacteria), and Julian Downward
(genome-wide screening of critical growth regulators in
human oncogenesis). They were complemented by Gita
Stockinger and Steve Jameson (T-cell homeostasis in health
and disease) and Doreen Cantrell (integration of serine
kinase signalling pathways).
The Institute has also become a world-renowned
centre for epigenetics, with eight groups working on
genomic imprinting, DNA methylation, chromatin
remodelling, non-coding RNA transcription, and
genome-wide nuclear organisation. ‘Epigenetic
mechanisms in development’ embraced the ‘hot’ topics
in epigenetics and epigenomics. Talks included the
epigenetic factors and processes that control stem cell
programming and genomic imprinting (Azim Surani,
Robert Feil, Austin Smith, Yehudit Bergman, Mandy
Fisher), higher order chromatin structure and dynamic
nuclear organisation of the genome (Wendy Bickmore,
Tom Misteli), roles of DNA methylation in health and
disease (Adrian Bird, Robert Feil), and X chromosome
inactivation (Edith Heard).
GRANT REPORTS
‘A very inspiring conference academically 
for a junior trainee like myself’
‘This meeting was, as usual, superb. Good mix of basic
and clinical science. Plenary sessions were of both clinical
and scientific interest/relevance’
‘All excellent plenaries. Provided a nice mix of science and
clinical endocrinology which was stimulating and useful’
comments from recipients of Society BES 2009 travel grantsSeveral speakers spanned both themes (Nicholas
Spitzer, genetic programming and calcium signalling in
neuronal stem cells; Anjana Rao, chromatin regulation of
lymphocyte commitment; Nullin Divecha, cytoplasmic
and nuclear phosphoinositide signalling).
The conference attracted 170 internal and external
delegates, and also included a poster session, with short
talks chosen from delegate abstracts. The Society for
Endocrinology generously contributed to this meeting and
the funding enabled Babraham to support the attendance
of graduate students and young post-doctoral scientists at
a considerably reduced cost, for which we are very grateful.
JENNY PELL
Small Grant 2007:
Stress threatens early pregnancy
by altering prolactin signalling
Stress threatens early pregnancy by its effects on
the hormone secretion and cytokine balance (Th1:Th2
ratio) required to maintain feto-maternal interface
integrity. Stress decreases secretion of progesterone,
in association with miscarriage/spontaneous abortion.
However, the neuroendocrine mechanism linking
stress perception to decreased hormone secretion is
not known.
Progesterone secretion is maintained in early
pregnancy by gonadotrophin secretion from the pituitary
and trophoblast/decidua including, importantly,
prolactin, and hCG. Uterine prolactin expression is a
marker for decidualisation. We hypothesised that in early
pregnancy stress profoundly reduces prolactin expression
and secretion when compared with virgins.
We analysed prolactin secretory responses to stress in
normal pregnant mice and in a mouse model of pregnancy
failure, and the underlying neuroendocrine (i.e. inhibitory
dopamine) mechanisms. We found that immune stress
(LPS), psychological stress for 24h or fasting for 24h all
decreased prolactin secretion in early pregnant mice. In the
mouse model of pregnancy failure prolactin decrease was
more profound than in C57/Bl6 mice. Increased activation
of hypothalamic dopaminergic neurones was revealed by
double immunocytochemistry, suggesting increased
dopamine activity. Therefore, relevant hypothalamic
responses to stress are enhanced and can explain the stress-
induced inhibition of prolactin.
Furthermore, increased expression of tyrosine
hydroxylase mRNA (the enzyme that generates
dopamine) was increased with stress. However, in mice
that were susceptible to pregnancy failure, expression
responses were different, indicating that in this model
other hypothalamic mechanisms interact with the stress
effects. Data on prolactin expression in the pituitary and
decidua are not yet available, and are still being
optimised. In association with decreased prolactin, stress
increases pregnancy-threatening cytokine expression
(e.g. IL6) more in early pregnancy than in virgin mice, so
there may be a cytokine/stress interaction which could
compromise pregnancy maintenance.
We are now building on these data to characterise other
neuroendocrine responses to stress in early pregnancy,
including their role in controlling prolactin secretion.
We thank the Society for Endocrinology for helping
to fund experiments to address this research. The
research has formed the basis of a grant application
already submitted to the MRC. The grant provided lab
consumables for a PhD student for a year and
strengthened external collaborations with the new co-
applicant on the submitted grant. On this basis I have
also been invited to speak at an international conference.
In addition to the direct benefits to the grant holder
and the PhD student, the student has subsequently
received other funding to travel to the collaborator’s lab
to learn new techniques, which we now intend to set up
and develop in Edinburgh. This supports the Centre for
Integrative Physiology’s aim to integrate different
approaches to further our understanding of physiological
systems. The PhD student involved in the project
experiments has joined the Society for Endocrinology.
ALISON DOUGLAS
Small Grant 2007:
Adenosine nucleotides in
communication between
osteoclasts and osteoblasts
I am grateful to the Society of Endocrinology for
their generous support, which has further developed
my on-going collaboration with Dr Bronwen Evans
(Child Health, Cardiff University) on the role of
adenosine nucleosides in the communication between
osteoclasts and osteoblasts.
A student undertaking laboratory training with us showed
that expression of the A2a and A2b adenosine receptors
increased as osteoclastogenesis progressed. Human osteoclast
proliferation also significantly increased (P<0.05) when
mononuclear cells were differentiated in vitro in the presence
of adenosine (10
-4M). On the other hand, incubation with
both human and rat osteoclast-conditioned medium caused
MG63 (osteoblast-like) cells to significantly decrease in
number. These osteoblasts, however, showed an increase in
alkaline phosphatase actvity (a marker of differentiation).
Intriguingly, the opposite results in relation to cell number (i.e.
an increase) and alkaline phosphatase activity (i.e. a decrease)
were obtained with the more differentiated SaOS-2
osteoblast-like cell line. These studies are on-going.
Part of the funding was used by our joint PhD student
to finish some studies on the adenosine regulation of
mesenchymal stem cell differentiation to osteoblasts and
adipocytes. These latter investigations have been
presented at various national meetings including the
annual meetings of the Society for Endocrinology and the
Bone Research Society. They are currently being written
up for publication and, together with our preliminary
studies on osteoblasts and osteoclast communication,
will form a basis for applications for external funding.
This Society for Endocrinology grant has clearly helped
the Centre of Endocrine and Diabetes Sciences, and me in
particular, to continue and expand the work on adenosine
and nucleotide signalling. The grant has helped to generate
findings that have initiated collaboration between
departments and schools, an interdisciplinary approach
which is strongly supported by Cardiff University.
JACK HAM
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Summer Studentship 2008:
An investigation into the
functional mechanism of AIP
Germline mutations were identified in a gene in
the 11q13.3 region encoding aryl-hydrocarbon
receptor (AhR)-interacting protein (AIP) in patients
with familial pituitary adenomas and occasionally in
sporadic cases. The 330-amino acid AIP is a molecular
chaperone protein, involved in the functional
maturation of AhR, an orphan nuclear receptor
known to bind the environmental toxin dioxin.
My laboratory has so far published functional data on
the effect of wild type and mutant AIP protein on cell
proliferation and protein-protein interaction and on the
expression and cellular location of AIP in both normal and
adenomatous pituitary tissue. We showed that over-
expression of wild type AIP slows down cell proliferation in
three different cell types, including a pituitary cell line. We
also showed that the mutations disrupt this function and
also the protein-protein interaction between AIP and its
known interacting partner, PDE4A5. Additionally, we
described the cellular distribution of AIP in normal pituitary
cells and showed its exclusive association with GH and
prolactin secretory vesicles. Though we showed that AIP
slows down cell proliferation we don’t know the specific
mechanisms/pathways through which it acts.
During this Summer Studentship, the student (Sophie
Hollington) investigated the potential role of AIP in the
apoptosis pathway. For this investigation, GH3 and HEK293
cells were transfected with wild type AIP, mutant AIP and
empty vector. After 24-48h a luminescent caspase 3/7 assay
was carried out on the transfected cells. The effect of AIP
on the cell cycle proteins was also investigated. GH3 and
HEK293 cells were transfected with wild type and mutant
AIP. Successful transfection was confirmed using a myc-
tagged antibody on Western blot. Western blotting was
used to investigate the expression of p27, p16, p18 and
cyclin D3, comparing the cells over-expressing wild type
AIP and empty vector as well as wild type and mutant AIP.
The apoptosis results showed that the effector caspase
(3/7) activity is significantly increased in cells over-
expressing wild type AIP compared with empty vector,
and also that this effect is partially lost in cells over-
expressing the mutant AIP. This was shown to be the case
in both the pituitary cell line (GH3 cells) and HEK293 cells.
No conclusive results were found with the cell cycle
protein expression and AIP over-expression, because of
time taken to optimise the antibodies, variable transfection
success, and other factors. However, one preliminary result
suggests that phophorylated p27 expression is reduced
when wild type AIP is overexpressed.
In conclusion, AIP exerts its tumour suppressor role, at
least to some extent, via apoptosis. Further work on upstream
caspases would provide more understanding of this potential
mechanism. An abstract has been entered into the Barts and
the London Medical School William Harvey Day and the RSM
Students’ Group Research Presentation prize, and is planned
for submission to the next Society BES meeting later this year
as a result of the work completed during this Studentship. We
are very grateful to the Society for this support.
MÁRTA KORBONITS
Summer Studentship 2008:
11βHSD1 inhibitors in atherosclerosis
The Society’s Studentship allowed me to carry out
10 weeks of very enjoyable and interesting research
into the role of 11βHSD1 inhibitors in atherosclerosis
at Queens Medical Research Institute, University of
Edinburgh.
I was able not only to increase my knowledge of the
scientific approaches, but also to learn some very
valuable laboratory skills, such as chromatography and
real-time PCR. Before the project I had never carried out
any in vivo work, but now I feel I can handle and use
animals effectively in any future experiments. The time
period allowed me to take time to thoroughly develop
the methods. I have gained considerably more
experience in presenting data and preparing reports of
experimental findings, and some of the generic skills in
computing are already benefiting me in my assignments
in my undergraduate studies.
I also enjoyed working with fellow members of staff
on the projects and learning how to plan and manage
my experiments. I was able to attend research talks and
institute symposia, and really enjoyed being part of that
environment. I hope to present my work at a conference
for medical students aimed at promoting research careers
in undergraduate medicine (ATRIUM), where I will gain
experience in preparing a poster and discussing my
work. I took the opportunity during the summer to
discover the possibilities of studying for a PhD, and was
advised on the approach to take to put myself in a
competitive position when the time comes.
Overall, it was an immensely valuable experience
which I will recommend to others. I shall keep in contact
with my supervisors and I hope to submit an essay for
the Undergraduate Essay Prize around the topic in the
spring. I also hope to have the opportunity to attend the
Society BES meeting next year when the studies are
complete and being presented.
KATIE SULLIVAN
‘We are very grateful for this funding. I think the
recipient has particularly benefited. In a very short time
she has gained confidence in the lab and is now able to
design well-controlled experiments. As part of the
experience I asked her to make the first draft on which
this report is based’
comment received with Summer Studentship 2008 
grant report
‘This Undergraduate Achievement Award is an excellent
idea. It will enable us to further raise the profile of
endocrinology in the undergraduate course, and will
help us to persuade the best students of the attraction of
a career in this field. We are most grateful to the Society
for the opportunity to do so in this way’
comment received with Undergraduate Achievement Award
grant reportAfter completing my first degree in molecular
biology and genetics in 2004 at the Democritus
University of Thrace, Greece, I decided to acquire more
knowledge and specialise in reproductive science.
I started a project based MSc in reproductive biology
at the University of Edinburgh. Joining UK academic life
was a great challenge. However, I soon became keen to
continue my studies for a PhD, and was very lucky to be
awarded a 3-year Principal’s PhD Studentship at
Edinburgh, to study the role of steroid hormone signalling
in human ovarian surface epithelium wound healing.
I spent 3 years with Professors Ian Mason and Steve
Hillier investigating how steroid biosynthetic enzymes and
steroid receptors are regulated during ovulation-associated
inflammation, and how this is relevant to the development
of epithelial ovarian cancer. It was really exciting, and an
honour for me, that this project was selected for
presentation as a Young Endocrinologists Prize Lecture at a
meeting as prestigious as Society for Endocrinology BES
2009. I thank the Society for Endocrinology for this award,
and for its financial support, which has allowed me to
attend national and international endocrine meetings, and
to present my data there.
After obtaining my PhD in January 2009, I started my
first post-doc at Imperial College London, in Professor
Catherine Williamson’s research group. We are
investigating the development of metabolic deficiencies in
the offspring of cholestatic mothers. We hope our findings
will improve the well-being of pregnant women and the
delivery of healthy offspring. This post-doctoral fellowship
will definitely give me the opportunity to develop my skills
and qualifications that will progress my academic career.
I fully anticipate that membership of the Society for
Endocrinology will provide an important contribution to
my career development.
GEORGIA PAPACLEOVOULOU
Following MRCP, I entered the specialty of
endocrinology in 2002, and was originally based in the
northern region. In 2004, I was awarded a clinical training
fellowship based at the Oxford Centre for Diabetes,
Endocrinology and Metabolism (OCDEM). This led to the
award of a DPhil from the University of Oxford.
During my research at OCDEM, I was extremely
fortunate to have Professors Wass and McCarthy as my
supervisors. They have been incredibly supportive and
I am indebted to them. This, combined with the unique
environment that OCDEM has to offer in terms of
expertise, facilities and collaborative opportunities,
enabled me to develop as a researcher. It also facilitated a
fruitful period which resulted in the publication of over 10
papers in peer-reviewed journals and numerous invitations
to speak at both national and international meetings.
My research studies at OCDEM were based on
polycystic ovary syndrome (PCOS). More specifically,
I performed genetic studies and also focused on metabolic
aspects of this highly prevalent and hugely important
endocrine condition. I was fortunate to have Professor Steve
Franks (Imperial College London) as a close collaborator.
He provided invaluable support and inspiration, and without
him much of my work would not have been possible.
One of the genetic studies resulted in the identification
of genome-sequence variants within the FTO gene as the
first to convincingly be shown to be associated with
susceptibility to PCOS. This study was the subject of some
media interest and included an article posted on the BBC
website in March 2009. The award of the Young
Endocrinologist Clinical Prize Lecture has been a highlight of
my career. I feel privileged to have received it and it was an
honour to have been able to deliver my presentation to this
esteemed Society at the 2009 annual Society BES meeting.
One of the most important roles fulfilled by any Society
should be to recruit, enthuse, support and encourage its
younger members. I believe that the Society for
Endocrinology has fulfilled this important role to great effect
and continues to do so. The future of our specialty is
dependent upon the support provided to young
endocrinologists, and the ability to attract pre-specialised
doctors and medical students into endocrinology. The Society
for Endocrinology achieves this in numerous ways and long
may this continue. I would like to thank them personally for
their support during the early stages of my career.
TOM BARBER
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‘Prized’ lectureships
This year’s Young
Endocrinologists
Prize Lecturers
begin this
special issue on
education by
telling us a
little about
themselves, and
what the prizes
mean to them.
Georgia Papacleovoulou Tom Barber
In association with the
Clinical Endocrinology Trust
2–4 November 2009
Renaissance Manchester Hotel, Manchester, UK
www.endocrinology.org/meetings/2009/clinicalupdate2009/index.html
Third in the highly successful new series of clinical training events essential
for all trainees and new consultants in endocrinology and diabetes.
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This year saw 55 entrants for the competition, and
the quality of essays submitted was highly impressive.
Each was marked and ranked by a distinguished
panel, and the process was overseen by the Society’s
education representative to Council.
As in previous years, most entrants were medical
students (65%), with 25% of the essays from science
students and 10% from veterinary students. The
geographical range of universities represented was very
encouraging, extending from Brighton and Sussex
Medical School to Peninsula Medical School, Durham,
and Glasgow. For the first time we had an entry from a
post-1992 group university, which was most welcome.
Clearly this competition is ‘working’ as a way of
promoting endocrinology in universities.
Ultimately there could only be one winner, and the
top prize of £1000 was awarded to Adam Hexter,
currently in the second year of a 5-year MB BS course at
Barts and The London School of Medicine and Dentistry.
Part of his essay appears below; you can read the full
version with references online at www.endocrinology.org/
grants/prize_undergraduateessay.html.
The Society also awarded £250 to four runners-up:
Helen Butler (London), for ‘The obesity crises:
cannabinoid antagonists to the rescue!?’; Zi Wei Liu
(Cambridge), for ‘Love: written in the stars, or in our
hormones?’; John Ser Pheng Loh (London), for ‘Ghrelin -
the elixir pill to all?’; and Ann Powles (London), for ‘HRT:
high rate of total confusion’.
Undergraduate Essay Prize 2009
What is allosteric load?
The paradox of stress-induced harm on the body was
first considered by Hans Selye, with his concept of the
‘general adaptive syndrome’. Selye’s work left a platform
for subsequent studies that have yielded the more
comprehensive concepts of allostasis and allosteric load.
Allostasis is the process of achieving ‘stability through
change’ and is fundamental for maintaining homeostasis
during adversity. This occurs through allosteric systems,
such as the HPA axis and autonomic nervous system,
which have the capacity to ‘adapt’ to meet the demands
of internal or external stressors. Crucially, allostasis is only
advantageous to humans in moderation - allosteric load
refers to the pathophysiological consequences that
accompany excessive allostasis and is dubbed ‘the price
of adaptation’. The commonest mechanism behind
allosteric load is simply overwhelming and unrelenting
stress, with subsequent dysregulation of stress hormones.
Is there such a thing as ‘good stress’? Indeed there
is, exemplified by the feelings of satisfaction experienced
upon finishing a marathon - this is called eustress. Stress
associated with negative emotions is termed distress.
Interestingly eustress and distress use the same
physiological systems and thus are equally taxing.
However, the ‘perception of stress’ does influence
physiology. If a person feels that they have little control
over the stressors they face, referred to as an external
locus of control, then there is greater activation of the
HPA axis than in those people who are more in charge
of their lives.
But how exactly does stress ‘get under our skin’?
This is an excellent question. However, the mechanism
by which stress causes disease is not fully understood: is
it the direct neuroendocrine effects or the associated
adverse behaviours, such as alcoholism? The reality
probably involves both.
What does your friend look like after recent
overexertion at work? Let me guess, they appear ‘drained’
as if they have aged somewhat. Well such observations
prompted research that asked, ‘does stress accelerate the
rate at which people age?’ Cortisol is implicated in
increasing oxidative stress by decreasing antioxidant
enzymes and it has been observed that women who suffer
from greater stress experience greater oxidative DNA
damage, particularly to the telomeres, which are found to
be shorter than expected. Telomeres are the protective
regions of DNA that cap chromosomes, and the fact they
shorten with every cell division means telomere ‘shortness’
can be used to ascertain cell senescence. Intriguingly, the
fact chronic stress is associated with shortening of
telomeres suggests stress accelerates cellular ageing via
cortisol-induced telomere damage. This could account for
the phenomenon of earlier onset of age-related diseases in
chronically stressed individuals.
But if you are reading this basking in the knowledge
that you lead a somewhat laid back, luxurious lifestyle
then be warned: events that happen before birth can
also influence health in later life. Low birthweight babies
have been shown to be more prone to acquiring a
dysregulated HPA axis, higher cortisol levels in later life
and greater cardiovascular mortality. Moreover, chronic
maternal stress during pregnancy is associated with
impaired physical and cognitive development.
Even so, do not be disheartened. Stress is a fact of
British life but can only significantly damage health if we
allow it to. By taking charge and changing the way we
live and perceive our lives right now, we can all
minimise the harmful effects of stress. So when you next
hear the words ‘credit’ and ‘crunch’, bear in mind the
following statement made by the author Adabella
Radici, ‘If your teeth are clenched and your fists are
clenched, your lifespan is probably clenched.’
ADAM HEXTER
STRESS AND HEALTH: 
WHAT WILL BE THE TRUE ‘COST’ OF THE CREDIT CRUNCH?
An excerpt from the winning prize essay for 2009.Earlier this year, a new Education and Career
Development Sub-committee was set up, as a 
sub-group of the Science Committee.
This Sub-committee is looking at several new projects.
Probably the most important of these relates to the career
development of early career researchers. While there is a
limited amount that a scientific society can achieve in terms
of improving the job market for scientists, there are some
things that we can do. The Sub-committee is prompting
the Society to take a much more active lead in career
development. Enhanced career information on the website
provides endocrinologists with information about the range
of careers that is available to you: from academia to clinical
biochemistry, as well as writing, industry, publishing etc.
We are also looking at ways in which we can help junior
members with, for example, fellowship applications.
Through the Society, we aim to encourage the new Society
of Biology to lobby the government for an improved career
structure for scientists.
We hope in the future to be able to produce
educational materials to help colleagues in universities to
deliver an endocrinology curriculum. If anybody out
there has a good special study module that they use in
their medical school we’d really like to hear about it.
The Sub-committee has taken over the work of a
couple of working parties, such as the Education Working
Group, and has put this activity on a more formal basis.
We oversee established activities including the
Undergraduate Prize Essay Competition (now in its third
year), and this year have set up the Postgraduate Prize
Essay Competition. The Sub-committee is also involved in
planning the Young Endocrinologists Retreat in October,
as well as recruiting young endocrinologists to attend,
and helping with the actual delivery of the event.
JOY HINSON
CHAIR, EDUCATION AND CAREER DEVELOPMENT SUB-COMMITTEE
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Education and career development
HOW HORMONES SHAPE YOUR LIFE
The Society teamed up with Science Oxford in
May to host a very successful public lecture on sex
hormones. Professor Stephen Franks of Imperial
College London delivered an informative and engaging
talk, ‘How hormones shape your life: reproduction and
long-term health’, in which he explained the science
behind the female reproductive system.
Picturesque Oxford was the perfect setting for this
event, which began with a wine reception in the colourful
exhibition space of Science Oxford. The interactive exhibits
and eye-catching displays provided a relaxed atmosphere,
allowing the audience to mingle before the lecture. Armed
with drinks and nibbles, and eager to hear Professor Franks’
talk, they then made their way to the lecture theatre.
After a brief introduction from the Science Oxford
chair, Professor Franks gave an overview of the female
reproductive system, the hormones involved and their role
in the menstrual cycle to a captivated Oxford audience. He
described how women have a limited number of eggs that
rapidly decline in their 40s, and gave examples of
conditions that arise when the menstrual cycle fails.
The enthusiastic audience, many of whom were
regulars at Science Oxford, asked questions throughout
the talk and were keen to know whether researchers
were looking into delaying the menopause to allow
women to have children into their 50s. Professor Franks
deftly fielded the questions. He explained that, over the
last century, the age of onset of the menopause has
remained steady at around 50 years, but our life
expectancy has gradually increased. Equipped with many
more questions, the audience put Professor Franks
through his paces, and the debate continued over drinks
in the more informal setting of the exhibition space.
This was a highly successful evening and we were
encouraged by the level of knowledge and enthusiasm
from the audience. If you would like to watch the event,
it was recorded by Science Oxford, and the webcast is
available to view at www.scienceoxfordlive.com/watch-us.
We are extremely grateful to Science Oxford for
providing such a fantastic venue for the event and to
Professor Franks for giving an excellent talk. We were
delighted to collaborate with Science Oxford, and we look
forward to working with them again on future projects.
If you would like to take part in one of the Society’s public
events, please send your details to public@endocrinology.org.
REBECCA RAMSDEN
Life Sciences Careers Conference 2009
The Society of Biology Life Sciences Careers Conference takes
place 13:00–18:00 on Wednesday 25 November 2009 at King’s
College London.
The conference, sponsored by the Society for Endocrinology, will
provide information about the wide range of science-related careers
available to life science graduates. Presentations will cover careers
from academic research to environmental science and science
communication, a CV workshop (providing tips on how to ensure
you secure an interview for your perfect job), an exhibition, and the
opportunity to mingle with experts and ask informal questions over
lunch and afternoon refreshments.
Further information can be found at www.endocrinology.org/careers
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So starts The Tide Tables, a new play examining the
conscious experiences of mid-life for women and the
biomedical science that underlies these experiences.
This Wellcome Trust funded arts project is the
brainchild of Christine Watkins, a writer and performer
based in Hereford, with music composed by Sianed Jones
and Mary Keith. Through her theatre company
Honeysuckle Direction (www.honeysuckledirection.org),
Watkins aims to bring together the interconnected
realms of science and art to create vibrant and thought-
provoking work.
The Tide Tables sees Elin (played by Watkins) holidaying
by a beach and finding herself alone. This gives her the
opportunity to contemplate her life so far and the changes
she feels are happening to her body, over which she has
no control. Through spoken word, song and narrative, Elin
explores her feelings and experiences and looks ahead to
the direction that her life is taking. The play was premiered
at the Courtyard Centre for the Arts in Hereford, and the
Society was lucky enough to receive an invitation to go
along and find out what it was about.
The play is in essence a masterclass in endocrinology
by stealth, using a number of different formats to
introduce the audience to some quite complicated
biomedical theories while still maintaining clarity and
entertainment. It attracted a surprisingly wide cross-section
of the public, about 160 people in total, and the medium
proved to be a successful and innovative method to
communicate science, particularly to people who may not
be traditionally interested in this area.
Music was provided by the haunting tones of
Sianed Jones as the mysterious lifeguard figure, whose
thoughtful and reflective compositions echoed the
confusion and uncertainty experienced by Elin.
Humour and light-heartedness were most definitely
supplied by the ever-cheerful Beach Radio, a quartet of
singers led by Mary Keith, broadcasting the airwaves
from 49-56 FM, and coming to Elin in the middle of her
life to answer all her queries. Their songs covered a
dazzling array of topics from phytoestrogens and
hormone replacement therapy to osteoporosis, wrinkles
and even hormone cascades and gonadotrophin-
releasing hormone (I kid you not!) - a range of topics
every endocrinologist would be proud of!
The Tide Tables also aimed to explore the biomedical
changes behind the menopause, as well as the conscious
experience itself. Scientific input for the play was
provided by Professor Saffron Whitehead from
St George’s University of London. As well as giving a
guiding overview to the science contained in the play,
she participated in the performance itself by providing
a voice-over during the interval, examining the history
of hormone replacement therapy.
The history of the therapy ranged from the first curious
experiments, performed in 1889 by Charles-Edward
Brown-Séquard, in which he injected himself with a liquid
extracted from the testicles of guinea pigs and dogs (he
claimed he gained great benefit from this!), to modern
day techniques. Professor Whitehead also participated in
a workshop the next day, along with Christine Watkins,
to discuss the art and science of mid-life and how current
scientific research and knowledge were combined to form
the basis of the plot.
As a first performance, The Tide Tables was successful
in achieving its aim of engaging the audience in a
reflection of the biology and biochemistry of the middle
phase of our lives, and the different ways in which we
respond. Honeysuckle Direction is now planning further
performances of this production. For more information,
including a video clip of the performance, visit
www.honeysuckledirection.org/tidetables.
JENNIE EVANS
‘Ladies and gentlemen 
and seagulls - right in the middle of my life 
I find myself right in the middle of
a beach, an utterly deserted beach… ‘The Practical Biology website
(www.practicalbiology.org) is a
collaboration between the Nuffield
Foundation Curriculum Programme
and the Biosciences Federation
(BSF), with the Society for
Endocrinology amongst the
principal sponsors.
It provides teachers of biology at
all levels - from key stage 3 to A-level -
with a growing collection of quality-
assured practical protocols that
demonstrate a wide range of biological
concepts. Some protocols have tightly
specified learning outcomes, while
others could be used as starting points
for open-ended investigations.
Detailed technical notes provide
tips for teachers and technicians on
handling the materials involved, as
well as highlighting hazards and
providing preliminary information for
risk assessments. All the protocols have
been safety checked by CLEAPSS.
Student sheets focus attention on key
observations and offer opportunities
for students to evaluate the protocols.
The project has already provided
practical biology professional
development for teachers and
technicians in partnership with the
Science Learning Centres. This raises the
profile of the site with practising and
student teachers, and provides a chance
to gain direct feedback on the materials.
Several BSF members have
provided materials related to their
areas of interest, and there is scope
to develop more resources in this
way. One way to prepare A-level
students for undergraduate work is to
provide information about research
protocols with real research data that
they can analyse.
17 T H E   E N D O C R I N O L O G I S T   •   I S S U E   9 3   •   A U T U M N   2 0 0 9
Practical Biology
Critical illnesses such as severe sepsis,
head injury and burns have long been
known to have dramatic effects on
almost all hormonal systems. More
recently, basic and clinical research has
explored whether these changes protect
the body or, alternatively, worsen the
outcome of severe illness.
High profile, and controversial, trials examining
endocrine manipulations of cortisol and glucose levels in
critical illness have required improved communication
between endocrinologists and intensive care specialists.
Against this background, this book aims to summarise
current knowledge in this emerging field.
The first section deals with potentially life-threatening
endocrine problems that might present to the intensivist,
including thyroid disorders, hypoadrenalism,
phaeochromocytoma and diabetic emergencies. The
second looks at the endocrine response to critical illness.
Chapters include the responses of the somatotroph,
adrenal and thyroid axes to severe illness, as well as
sodium disorders and the use of intensive insulin regimens.
This works well and is a tribute to the experience of
the editor, who, more than anyone else, has developed
research into the endocrine response to critical illness,
which is reflected in her authorship of several chapters. The
other authors are also of the highest international standing.
It is likely that endocrinologists and intensivists
would each get something different from the book.
Endocrinologists would probably not gain much from the
chapters relating to common endocrine problems, or to
the use of catecholamines. Intensivists are likely to find
almost all the book useful, perhaps excepting some of
the material dealing with out-patient management.
Some aspects were frustrating. Values given for
cortisol, glucose and electrolytes are not the metric values
used in Europe, and no conversion factors are given. This
suggests the book is aimed at an American audience.
Likewise, routine and frequent liver function tests and
neutrophil counts in patients taking thionamides are stated
as essential, but are not recommended in the UK.
Inevitably, publications in fast-moving areas have
aspects that rapidly date. The chapters on intensive insulin
treatment will be affected by a recent high profile trial that
has probably altered the conclusions. In addition, the
chapter on glucocorticoid replacement contains an
unpublished meta-analysis strongly supporting the routine
use of hydrocortisone treatment in sepsis. This advice is
contrary to most current international recommendations
and I think this conclusion should have been tempered
accordingly.
Overall, the book will be of interest to many clinicians
at the interface of endocrinology and critical care. It will
be most important for rapid reference when a sick patient
with an endocrine problem is admitted to the critical care
unit. Although some chapters will become outdated
rapidly, they all provide a useful foundation and, for the
rarer conditions, are likely to provide important
emergency advice for many years to come.
MARK COOPER
Acute Endocrinology: from Cause to Consequence
G Van den Berghe (Ed), Humana Press, 2008, 316pp, £72, ISBN 978-1-60327-176-9
With the ongoing support of
organisations such as the Society for
Endocrinology, Practical Biology will
be able to provide innovative
resources that prepare school
One example
project:
making a
model lung
to investigate
asthma
students for further studies in biology
and help them understand the vital
contribution that biological science
makes to our understanding of the
world. Any endocrinologists out there
with ideas to offer should contact
jennie.evans@endocrinology.org.
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I grew up and went to school in London. The
secondary school was a long way from where I lived,
and I didn’t know a single other boy. In the first few
days at the new school, I became aware of a
longstanding tradition whereby the second year boys
chased the new boys and imprisoned them in the
‘bear-pit’ for the duration of the lunch break.
Not surprisingly, I did not like the sound of this
tradition, so when Gibbins, a second year, approached
me with capture in mind, it resulted in a fight.
I managed to get the better of Gibbins in the battle, not
difficult as he was no bigger than me. Gibbins then sent
for Mason, another second year, to deal with me. Mason,
however, was similar in height to Gibbins and again I got
the better of him and avoided capture. At this point
Gibbins and Mason sent for Tizer, and immediately I ran
and hid under a coat in the cloakrooms for the duration
of the lunch break!
That was a defining moment in my overall
development. In some ways it was encouraging; it
confirmed that I had good eyesight and a certain basic
intelligence with regard to self-preservation. As Tizer was
built like the side of a house and the ground shook as he
walked down the middle of any corridor in the school,
my expectation was an unpleasant death of the
traumatic variety, if he found me.
On the other hand it was also a sad occasion, as it
illustrated for the first time self awareness of my own
limitations and an acceptance of my cowardice in the
presence of fear. I was no longer pluripotential, the sky was
no longer the limit, certain achievements, such as standing
up bravely in opposition to Tizer, were beyond my capacity.
Knowing one’s limitations is an asset as a speaker too,
whether it be in an endocrine or any other type of
meeting. The duration of the talk is usually pre-determined
by the organising committee, irrespective of which, I find
it nearly impossible to listen to any speaker on any topic in
endocrinology for longer than 45 minutes. Occasionally,
however, one is forced to break the rules.
On a trip to Taiwan I was asked to give two talks
of 1 hour each, consecutively, to the local paediatric
club. The meeting was held on a Saturday
afternoon, with only a 7-minute break between
the talks. I indicated to the chairman, a local
geneticist, that I felt sorry for the audience
facing a 2-hour onslaught in the middle of their
weekend. He replied with disdain for my
objections, telling me that when he lectured it
was for never less than 4 hours at a time!
From bitter personal experience I realise how
hard it is for an audience to remain awake, alert
and stimulated during a lecture. About a year ago,
I was sent an audio CD of a talk that I had given 6
months earlier. I was quite excited, I had never heard
myself lecture. I played the CD and within 10 minutes
I was sound asleep, sitting bolt upright. To put this in
context, I have never previously or since fallen asleep in
a chair at my computer.
Nonetheless, whilst I have compassion for the
audience, the behaviour of certain members is galling.
So much so that I wonder if we have not reached the
stage when, instead of asking the audience to evaluate
the speaker, we should turn things around and ask the
speakers to evaluate their audience!
The list of complaints would include the reading of a
newspaper during a talk, the use of a mobile phone, and
the checking of email on their laptops. And what about
the farce which affects the question time of any speaker
giving the last talk before a coffee break or lunch? At
least two-thirds of the audience steam out as soon as the
talk is over – meaning that no questions can be asked
because they would be drowned out by the sound of
stamping feet, rushing their owners towards a drink
which is usually nothing more than lukewarm and
indeterminate in identity between tea and coffee.
Perhaps evaluation sheets should only be used for
new studies and/or fun. What if we decided to study
aspects of social behaviour of the delegates at the
meeting and gather objective data? I suggest we weigh
all delegates at registration and then again when they
leave the meeting several days later. This would allow us
to determine gender variation in weight gain over the
meeting period and, if international, we could calculate
national greed scores, which could be expressed as
absolute or percentage gain in weight. The study could
be extended to alcohol intake if liver function tests were
performed at the same time points.
Recently I enjoyed an evaluation-free meeting in
Berne, Switzerland. On the spare afternoon I had a
look at the sights. Berne is famous for its bear-pit.
I approached with caution, but it was not bears that I
was on the lookout for.
‘HOTSPUR’
Audience behaviour
bears closer evaluation
Journal of Endocrinol
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Understanding ghrelin’s effect on hunger
Kola and Korbonits review the actions of ghrelin in
suppressing appetite. Recent studies led the authors to
construct a hypothesis explaining the intracellular pathway
for ghrelin. The authors propose that many areas need more
investigation, including the pathways and mechanisms of
central ghrelin and its role in peripheral metabolism. Given
the increase in the number of patients with obesity, further
studies into ghrelin, AMPK and other factors involved in
appetite regulation are extremely important.
‹ DOI: 10.1677/JOE-09-0056 
HPA response to oestrogen
This study by Evuarherhe and colleagues addresses how
oestrogens in the peripubertal period influence pituitary-
adrenal activity. The authors show that oestrogens
administered during this period attenuate ACTH and
corticosterone responses to stress, in contrast to the
stimulatory action of oestrogens on the adult HPA axis. This
research further suggests that exposure to sex steroids in
the neonatal period programmes adult HPA activity, while
in puberty a non-sex-steroid-dependent process develops
the stimulatory effect of oestrogens on the HPA axis.
‹ DOI: 10.1677/JOE-09-0175
Maternal nicotine during lactation
This study by Oliveira and coworkers examines the effects
of maternal nicotine during lactation in rats, and the effects
this may have on the adiposity and thyroid status of the
offspring. If the findings translate to humans, this may
explain the prevalence of obesity in children exposed to
cigarette smoke during the perinatal period. The study
found that nicotine imprints a neonatal thyroid dysfunction
and programmes for a higher adiposity, hyperleptinaemia
and secondary hypothyroidism in adulthood.
‹ DOI: 10.1677/JOE-09-0020
Ghrelin and GH interaction
A model by Wagner and coworkers of the interactions of
ghrelin with the GH neuroendocrine axis has predicted
that ghrelin stimulates the secretion of neuropeptide Y,
and that it has different functions at the hypothalamus
and the pituitary. These novel features were
experimentally verified and contribute to the better
understanding of the in vivo role of ghrelin.
‹ DOI: 10.1677/JME-09-0023
GATA4 in the heart and gonads
The implications of deficiencies of the transcription factor
GATA4 have been studied by Thurisch and colleagues.
Transgenic mice showed that decreased Gata4 expression
was associated with decreased expression of known cardiac
genes, and of different downstream target genes in the
ovary and testis, affecting the function and integrity of the
gonads. These findings have implications for patients with
inherited GATA4 deficiency.
‹ DOI: 10.1677/JME-09-0030
Journal of Endocrinology
JOURNAL OF
MOLECULAR ENDOCRINOLOGY
TSH in thyroid cancer
Two recent studies showed that high TSH levels are
associated with increased risk of developing papillary thyroid
cancer in patients with thyroid nodules. This paper by Fiore
and colleagues confirms this in a very large cohort of
subjects (>10 000), and extends the observation by showing
that patients with low TSH levels have diminished risk of
thyroid cancer. These findings suggest that TSH may play a
fundamental role in thyroid cancer initiation or progression.
‹ DOI: 10.1677/ERC-09-0036
MicroRNA in adrenocortical cancer
Adrenocortical cancer pathogenesis is incompletely
understood. Tombol and colleagues applied a combined
microRNA (mIR) and mRNA expression profile to distinguish
benign adenomas from carcinomas (ACC). They found that
expression of miR-184 and miR-503 was significantly higher,
whereas that of miR-511 and miR-214 was significantly lower
in ACCs than in other groups. Two of these, mIR-511 and
mIR503, are sufficient to provide diagnostic discrimination.
The expression profiles also hint at a possible dysfunction of
the G2/M cell cycle checkpoint in ACC pathogenesis.
‹ DOI: 10.1677/ERC-09-0096
Vitamin D in severe obesity
Stein and colleagues assessed the influences of race, sun
exposure and dietary intake on vitamin D status, and
evaluated two vitamin D repletion regimens prior to
surgery in extremely obese patients. The study shows that,
in severely obese individuals, those who are African
American, have a higher BMI and limited sunlight
exposure are at greatest risk for vitamin D insufficiency,
factors which can identify at-risk patients for vitamin D
repletion prior to bariatric surgery.
‹ DOI: 10.1111/j.1365-2265.2008.03470.x
TSH and vascular inflammation
Desideri and coworkers evaluated the effect of
recombinant human TSH (rhTSH) on biomarkers of
vascular endothelial cell and platelet activation in patients
monitored for thyroid carcinoma remnant. This study
provides the first evidence that TSH is associated with
proatherogenic activation of vascular endothelial cells and
platelets, and enhanced lipid peroxidation. It remains to
be demonstrated that this detrimental proinflammatory
and proatherosclerotic phenotype might also occur due
to the mild but persistent TSH elevation observable in
patients with chronic hypothyroidism.
‹ DOI: 10.1111/j.1365-2265.2008.03485.x
TSH diagnoses hypopituitarism
Jostel and colleagues propose a TSH index method, which
provides an accurate estimate of the severity of pituitary
dysfunction in hypopituitary patients based on simple
thyroid function tests. The method predicts the probability
of pituitary stimulation test failure and extends the
diagnosis of TSH deficiency into areas of the normal thyroid
function test reference range. A subnormal TSH index
could provide an indication of central hypothyroidism in
patients without primary thyroid disease.
‹ DOI: 10.1111/j.1365-2265.2009.03534.x
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2% testosterone gel
The ﬁrst metered dose
A simple solution to a serious problem